Open Access iconOpen Access

ARTICLE

crossmark

Prognostic prediction and expression validation of NSD3 in pan-cancer analyses

SHA LI1,2,#, YAQIONG LIU3,#, CHAOLING YAO1, ANJI XU1, XIAOLING ZENG4, YUXIN GE4, XIAOWU SHENG4, HAILIN ZHANG1,2, XIAO ZHOU1,2,*, YING LONG1,2,*

1 Translational Medicine Centre, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya, School of Medicine, Central South University, Changsha, China
2 Hunan Provincial Clinical Research Centre for Oncoplastic Surgery, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya, School of Medicine, Central South University, Changsha, China
3 School of Medicine, College of Medicine, Nursing and Health Science, National University of Ireland, Galway, Ireland
4 Central Laboratory, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya, School of Medicine, Changsha, China

* Corresponding Authors: XIAO ZHOU. Email: email; YING LONG. Email: email
# Sha Li and Yaqiong Liu contributed equally to this paper. They are co-first authors

TSP_BIOCELL_27209.pdf

  • 937

    View

  • 654

    Download

  • 0

    Like

Share Link